The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target

E-ISSN： 1873-5592|12|5|709-723

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.5, 2011-05, pp. : 709-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 3, 2010-09 ,pp. : 224-234

Bentham Science Publishers

Access to resources Recommend Favorite

Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca2+ Release Channel: Case Study of Dantrolene

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-01 ,pp. : 1062-1072

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor-operated Ca 2+ influx channels in leukocytes: a therapeutic target?

By Li S.W. Westwick J. Poll C.T.

Trends in Pharmacological Sciences, Vol. 23, Iss. 2, 2002-02 ,pp. : 63-70

Elsevier

Access to resources Recommend Favorite

Cyclic ADP-ribose, the ryanodine receptor and Ca 2+ release

By Sitsapesan R. McGarry S.J. Williams A.J.

Trends in Pharmacological Sciences, Vol. 16, Iss. 11, 1995-11 ,pp. : 386-391

Elsevier

Access to resources Recommend Favorite

The CCR2 receptor as a therapeutic target

By Feria Manuel Díaz-González Federico

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 49-57

Informa Healthcare

Access to resources Recommend Favorite